positions available now

Tag Archives: Regulatory Reform

Making the most of complementary medicines reforms

In March this year the TGA finally started rolling out the long awaited Complementary Medicine Reforms.    One of the most significant changes for sponsors of listed complementary medicines is the abolition of the “free text” box for indications.  All … Continue reading

Posted in Regulatory Services, TGA | Tagged , , , | Comments Off on Making the most of complementary medicines reforms

Independent Review of Medicines and Medical Devices Regulation

This week, Pharma in Focus interviewed one of our Senior Regulatory consultants, Dr Greg Pearce, for his commentary on the stage 1 report from the independent review of Medicines and Medical Devices regulation. Released last month, the report is currently … Continue reading

Posted in Life Sciences Industry, Regulatory Services, TGA | Tagged | Comments Off on Independent Review of Medicines and Medical Devices Regulation

Industry Insight – Ready for Joint Implant Reclassification?

Industry Insight is a new regular feature of Eye Spy. This month we address the latest challenge for sponsors of medical devices. Continue reading

Posted in Regulatory Services, TGA | Tagged , | Comments Off on Industry Insight – Ready for Joint Implant Reclassification?

Business Process Reform at the TGA

The TGA are proposing the most significant changes to the evaluation process for prescription medicines in nearly 20 years. In this article, the proposed changes are summarised and the potential effects for industry are discussed. Continue reading

Posted in Regulatory Services, TGA | Tagged | Comments Off on Business Process Reform at the TGA
Copyright © 2014 Commercial Eyes